Stock Evaluator: Seer, Inc. (SEER)

Seer, Inc. SEER

$2.22 0.16 7.77%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 2,903,331
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Life Sciences Tools & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Commentary & Analysis


Financial Summary

Share Statistics SEER Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $122.1 $1,790.4 23%
Shares Out (Mil) 56.0 94.8 50%
Institutional Ownership 71.0% 90.0% 43%
Float (Mil) 40.1 69.9 42%
Beta 1.59 1.20 84%
Avg Daily Volume (000s) 1,654 814 79%
Price Change
(52-week)
2.3% 80.2% 47%
Growth SEER Industry
Median
Percentile
(All Stocks)
Sales (5yr) 88.4% 7.8% 98%
Net Income (5yr) (17.5%) (13.7%) 23%
EPS (5yr) 12.4% 0.7% 51
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (65.9%) (15.0%) 3%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 2 2
Current EPS ($0.270) ($1.045) ($0.980)
Month Ago EPS ($0.270) ($1.045) ($0.980)
# Rev Up 1 0 0
# Rev Down 0 1 1
Three Months Ago EPS ($0.280) ($1.080) ($1.050)
Year/Year Chg (10.3%) (18.4%) (28.2%)
Financials SEER Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $15 $785 11%
Net Income (TTM) (Mil) ($71) ($14) 13%
EPS (TTM) ($1.246) ($0.200) 19%
Operating Cash Flow (TTM) (Mil) ($49) $53 9%
Net Cash Flow (TTM) (Mil) ($5) ($4) 34%
Long-Term Debt (Q1) (Mil) $20 $270 33%
Enterprise Value (Q1) (Mil) ($50) $2,444 1%
Valuation SEER Industry
Median
Percentile
(All Stocks)
P/B 0.51 2.92 9%
P/E na 43.7 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 5.3 na
Ratios SEER Industry
Median
Percentile
(All Stocks)
Gross Margin 48.7% 47.6% 61%
Net Margin (464.8%) (2.9%) 2%
ROA (22.8%) (2.8%) 19%
ROE (25.5%) (4.5%) 22%
Liabilities to Assets 11.3% 43.0% 7%
F-Score 3 5 19%

Seer, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors